Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Sdr16c5 and Sdr16c6 genes regulate a key point in lipid production that affects eye and skin gland function.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

Abrocitinib may effectively treat Lichen Planopilaris.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

Liposomal delivery systems improve drug absorption through the skin, offering potential for better treatments.

A woman got a scalp condition from using latanoprost, but it improved after stopping the drug and starting other treatments.

A young woman with visual issues and other symptoms was diagnosed with lupus and antiphospholipid syndrome, and improved with treatment.

Patients with lichen planopilaris have a higher risk of heart disease.

Researchers found that certain lipids, especially vitamin D3, are lower in prematurely grey hair than in pigmented hair.

Liposomes could improve how skin care products work but are costly and not very stable.

CRISPR gene editing reduces harmful molecules in cells from Emery–Dreifuss Muscular Dystrophy patients.

Both fluoxetine and clomipramine effectively treat dog lick dermatitis, but fluoxetine works faster with lower recurrence, while clomipramine has fewer side effects.

Eyelash loss can be a sign of thyroid problems.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Matrix effects in LC-MS can be managed but not completely avoided.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

Ritlecitinib works well and is safe for treating alopecia areata.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

TNF-alpha inhibitors can cause various immune-related skin issues.

The research explains how a human enzyme binds and processes its substrate, which could relate to its role in biological functions and hair loss.

Oral minipulse therapy effectively treated bullous lichen planus in a 35-year-old woman.

Targeting Hedgehog signaling may help treat ligamentum flavum fibrosis.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Applying minoxidil can help improve hair growth in people with hair loss caused by LIPH gene mutations.